Llwytho...
DD-05 GSK3BETA INHIBITORY DRUGS ATTENUATE INVASION OF GLIOBLASTOMA CELLS
PURPOSE: Glycogen synthase kinase (GSK) 3beta is an emerging and attractive therapeutic target against glioblastoma (GBM). Here, we investigated the efficacy of existing approved drugs inhibiting GSK3beta activity in vitro and in vivo on the basis of drug repositioning. METHOD: The effects of GSK3be...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218035/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou246.5 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|